Successful treatment of Scedosporium apiospermum soft tissue abscess with caspofungin and voriconazole in a severely immunocompromised patient with acute myeloid leukemia

Transplant Infectious Disease

Volumn 12, Issue 6, 2010, Pages 538-542

  Beier, F ^a   Kittan, N ^a   Holzmann, T ^a   Schardt, K ^a   Andreesen, R ^a   Holler, E ^a   Hildebrandt, G C ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Allogeneic stem cell transplantation; Caspofungin; Combination therapy; Pseudallescheria boydii; Scedosporium apiospermum; Soft tissue abscess; Voriconazole

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CIPROFLOXACIN; CLINDAMYCIN; CYTARABINE; FLUCONAZOLE; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN; POSACONAZOLE; PYRIMETHAMINE; SULBACTAM; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INFECTION PREVENTION; LEUKOCYTE COUNT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PETRIELLIDIUM BOYDII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; SCEDOSPORIUM APIOSPERMUM; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT DURATION;

ABSCESS; ANTIFUNGAL AGENTS; ECHINOCANDINS; FEMALE; FOREARM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MYCETOMA; PYRIMIDINES; SCEDOSPORIUM; SOFT TISSUE INFECTIONS; TREATMENT OUTCOME; TRIAZOLES;

EID: 78650110533     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2010.00537.x     Document Type: Article

References (26)

1. Cuenca-Estrella M, Alastruey-Izquierdo A, Alcázar-Fuoli L, et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans. Antimicrob Agents Chemother 2008; 52: 1136-1139.
2. Gilgado F, Serena C, Cano J, Gene J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211-4213.
3. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157-197.
4. Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005; 23: 5675-5687.
5. Pagano L, Caira M, Falcucci P, Fianchi L. Fungal CNS infections in patients with hematologic malignancy. Expert Rev Anti Infect Ther 2005; 3: 775-785.
6. Safdar A, Papadopoulos EB, Young JW. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002; 4: 212-217.
7. Kantarcioglu AS, Guarro J, De Hoog GS. Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome. Mycoses 2008; 51: 275-290.
8. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005; 43: 4930-4942.
9. Gilgado F, Cano J, Gene J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008; 46: 766-771.
10. Guarro J, Kantarcioglu AS, Horre R, et al. Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 2006; 44: 295-327.
11. Tadros TS, Workowski KA, Siegel RJ, Hunter S, Schwartz DA. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis. Hum Pathol 1998; 29: 1266-1272.
12. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 2001; 17: 531-570.
13. Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E. Scedosporium apiospermum infection after near-drowning. Mycoses 2007; 50: 412-421.
14. Schaenman JM, Digiulio DB, Mirels LF, et al. Scedosporium apiospermum soft tissue infection successfully treated with voriconazole: potential pitfalls in the transition from intravenous to oral therapy. J Clin Microbiol 2005; 43: 973-977.
15. Uenotsuchi T, Moroi Y, Urabe K, et al. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol 2005; 85: 156-159.
16. Matsumoto Y, Oh I, Nagai A, et al. Case of cutaneous Scedosporium apiospermum infection successfully treated with voriconazole. J Dermatol 2009; 36: 98-102.
17. Pasqualotto AC, Denning DW. New and emerging treatments for fungal infections. J Antimicrob Chemother 2008; 61 (Suppl 1): i19-i30.
18. Lamaris GA, Chamilos G, Lewis RE, et al. Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43: 1580-1584.
19. Bhatti Z, Shaukat A, Almyroudis NG, Segal BH. Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients. Mycopathologia 2006; 162: 1-15.
20. Bonduel M, Santos P, Turienzo CF, Chantada G, Paganini H. Atypical skin lesions caused by Curvularia sp and Pseudallescheria boydii in two patients after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 27: 1311-1313.
21. Tong SY, Peleg AY, Yoong J, et al. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transpl Infect Dis 2007; 9: 241-243.
22. Nonaka D, Yfantis H, Southall P, Sun CC. Pseudallescheriasis as an aggressive opportunistic infection in a bone marrow transplant recipient. Arch Pathol Lab Med 2002; 126: 207-209.
23. Gilgado F, Cano J, Gene J, Serena C, Guarro J. Different virulence of the species of the Pseudallescheria boydii complex. Med Mycol 2009; 47: 371-374.
24. Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47: 106-117.
25. Mursch K, Trnovec S, Ratz H, et al. Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode. Childs Nerv Syst 2006; 22: 189-192.
26. Guignard S, Hubert D, Dupont B, et al. Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient. J Cyst Fibros 2008; 7: 89-91.